Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency

Blood

Volumn 126, Issue 3, 2015, Pages 397-405

  Pike, Gillian N ^a,b   Cumming, Anthony M ^a   Hay, Charles R M ^a,b   Bolton Maggs, Paula H B ^b,c   Burthem, John ^a,b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Manchester Blood Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; FIBRINOGEN; THROMBIN; THROMBOPLASTIN; TRYPSIN INHIBITOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASSAY; BLEEDING TENDENCY; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PHENOTYPE; PRIORITY JOURNAL; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THROMBIN GENERATION ASSAY; THROMBOCYTE COUNT; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD SAMPLING; CASE CONTROL STUDY; CELL CULTURE; COMPARATIVE STUDY; COMPLICATION; HEMORRHAGE; LABORATORY DIAGNOSIS; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; WESTERN BLOTTING;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; BLOOD SPECIMEN COLLECTION; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELLS, CULTURED; FACTOR XI; FACTOR XI DEFICIENCY; HEMORRHAGE; HUMANS; PHENOTYPE; SPECIMEN HANDLING; THROMBIN;

EID: 84937703523     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-12-616565     Document Type: Article

References (32)

1. Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med. 1991;325(3):153-158.
2. Salomon O, Steinberg DM, Seligshon U. Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy. Haemophilia. 2006;12(5):490-493.
3. Bolton-Maggs PH, Young Wan-Yin B, McCraw AH, Slack J, Kernoff PB. Inheritance and bleeding in factor XI deficiency. Br J Haematol. 1988;69(4):521-528.
4. Bolton-Maggs PH, Patterson DA, Wensley RT, Tuddenham EG. Definition of the bleeding tendency in factor XI-deficient kindreds - a clinical and laboratory study. Thromb Haemost. 1995;73(2):194-202.
5. Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PN. Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood. 1985;65(3):719-724.
6. Bolton-Maggs PH, Colvin BT, Satchi BT, Lee CA, Lucas GS. Thrombogenic potential of factor XI concentrate. Lancet. 1994;344(8924):748-749.
7. Bolton-Maggs P, Goudemand J, Hermans C, Makris M, de Moerloose P. FXI concentrate use and risk of thrombosis. Haemophilia. 2014;20(4):e349-e351.
8. Davie EW, Ratnoff OD. Waterfall Sequence for Intrinsic Blood Clotting. Science. 1964;145(3638):1310-1312.
9. Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem. 1991;266(12):7353-7358.
10. Gailani D, Broze GJ Jr. Factor XI activation in a revised model of blood coagulation. Science. 1991;253(5022):909-912.
11. Maas C, Meijers JC, Marquart JA, et al. Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma. Proc Natl Acad Sci USA. 2010;107(20):9083-9087.
12. Kravtsov DV, Matafonov A, Tucker EI, et al. Factor XI contributes to thrombin generation in the absence of factor XII. Blood. 2009;114(2):452-458.
13. Wielders SJ, Béguin S, Hemker HC, Lindhout T. Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available. Arterioscler Thromb Vasc Biol. 2004;24(6):1138-1142.
14. Oliver JA, Monroe DM, Roberts HR, Hoffman M. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol. 1999;19(1):170-177.
15. Rugeri L, Quélin F, Chatard B, De Mazancourt P, Negrier C, Dargaud Y. Thrombin generation in patients with factor XI deficiency and clinical bleeding risk. Haemophilia. 2010;16(5):771-777.
16. Livnat T, Martinowitz U, Mansharov R, Zivelin A, Salomon O. Thrombin generation test can predict bleeding tendency in patients with severe factor XI deficiency [abstract]. Blood. 2013;122(21):3600a.
17. Guéguen P, Galinat H, Blouch MT, et al. Biological determinants of bleeding in patients with heterozygous factor XI deficiency. Br J Haematol. 2012;156(2):245-251.
18. Zucker M, Seligsohn U, Salomon O, Wolberg AS. Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency. J Thromb Haemost. 2014;12(7):1121-1130.
19. Collins PWGE, Lilley P, Pasi KJ, Lee CA. Clinical experience of factor XI deficiency: the role of fresh frozen plasma and factor XI concentrate. Haemophilia. 1995;1:227-231.
20. Hemker HC, Giesen P, AlDieri R, et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb. 2002;32(5-6):249-253.
21. Falls LA, Furie B, Furie BC. Role of phosphatidylethanolamine in assembly and function of the factor IXa-factor VIIIa complex on membrane surfaces. Biochemistry. 2000;39(43):13216-13222.
22. von dem Borne PA, Mosnier LO, Tans G, Meijers JC, Bouma BN. Factor XI activation by meizothrombin: stimulation by phospholipid vesicles containing both phosphatidylserine and phosphatidylethanolamine. Thromb Haemost. 1997;78(2):834-839.
23. Keularts IM, Zivelin A, Seligsohn U, Hemker HC, Béguin S. The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thromb Haemost. 2001;85(6):1060-1065.
24. Cawthern KM, van 't Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG. Blood coagulation in hemophilia A and hemophilia C. Blood. 1998;91(12):4581-4592.
25. Hansson KM, Nielsen S, Elg M, Deinum J. The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood. J Thromb Haemost. 2014;12(10):1678-1686.
26. Gailani D, Broze GJ Jr. Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation. Blood. 1993;82(3):813-819.
27. Wuillemin WA, Mertens K, ten Cate H, Hack CE. Thrombin-mediated activation of endogenous factor XI in plasma in the presence of physiological glycosaminoglycans occurs only with high concentrations of thrombin. Br J Haematol. 1996;92(2):466-472.
28. von dem Borne PA, Meijers JC, Bouma BN. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood. 1995;86(8):3035-3042.
29. Choi SH, Smith SA, Morrissey JH. Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood. 2011;118(26):6963-6970.
30. Leiba H, Ramot B, Many A. Heredity and coagulation studies in ten families with Factor XI (plasma thromboplastin antecedent) deficiency. Br J Haematol. 1965;11(6):654-665.
31. Dargaud Y, Luddington R, Gray E, et al. Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study. Br J Haematol. 2007;139(2):303-309.
32. Dargaud Y, Luddington R, Gray E, et al. Standardisation of thrombin generation test - which reference plasma for TGT? An international multicentre study. Thromb Res. 2010;125(4):353-356.